Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT05679466
What this trial is testing

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Who this might be right for
Prevention of COVID-19 Caused by SARS-CoV-2
Yu Qin 3,300
Large-scale testing (Phase 3)Ended earlyNCT02859727
What this trial is testing

Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI

Who this might be right for
Activated PI3Kdelta Syndrome (APDS); PASLI Disease
Pharming Technologies B.V. 37
Testing effectiveness (Phase 2)Looking for participantsNCT06988956
What this trial is testing

Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University 95
Not applicableStudy completedNCT03068637
What this trial is testing

Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Carevive Systems, Inc. 165
Not applicableStudy completedNCT05940337
What this trial is testing

FIT to Grow Old - Functionality of the Immune System and Healthy Aging

Who this might be right for
Aging
Wageningen University 156
Testing effectiveness (Phase 2)Study completedNCT01013675
What this trial is testing

Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly

Who this might be right for
Influenza Vaccines
Abbott Biologicals 622
Not applicableStudy completedNCT01746030
What this trial is testing

Geriatric Assessments in Senior Adults With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 42
Testing effectiveness (Phase 2)Study completedNCT01025505
What this trial is testing

Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study

Who this might be right for
TreatmentStem Cell Transplantation
Gruppo Italiano Malattie EMatologiche dell'Adulto 40
Not applicableStudy completedNCT00198406
What this trial is testing

A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.

Who this might be right for
ELDERLY PEOPLENon-small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 1,653
Not applicableUnknownNCT06539221
What this trial is testing

Sphingolipids in Asthma Pathogenesis

Who this might be right for
Asthma
Peking University Third Hospital 200
Not applicableLooking for participantsNCT05902416
What this trial is testing

Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Peking University People's Hospital 120
Testing effectiveness (Phase 2)UnknownNCT05428670
What this trial is testing

The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.

Who this might be right for
Diffuse Large B Cell Lymphoma
First Affiliated Hospital of Wenzhou Medical University 150
Testing effectiveness (Phase 2)Study completedNCT05770180
What this trial is testing

Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell)

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 450
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06778902
What this trial is testing

AZA Combined with R-GemOx for Elderly DLBCL Patients

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04891809
What this trial is testing

Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM

Who this might be right for
Newly Diagnosed Multiple Myeloma
Arbeitsgemeinschaft medikamentoese Tumortherapie 198
Testing effectiveness (Phase 2)Study completedNCT00689000
What this trial is testing

Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeMultiple Myeloma
Chroma Therapeutics 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT04765111
What this trial is testing

Acalabrutinib and Rituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565521
What this trial is testing

UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly

Who this might be right for
Glioblastoma Multiforme, AdultGlioblastoma, IDH-mutant
Sunnybrook Health Sciences Centre 55
Testing effectiveness (Phase 2)UnknownNCT04396457
What this trial is testing

Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

Who this might be right for
Non-squamous Non-small-cell Lung CancerCancer, Lung
National Hospital Organization Nagoya Medical Center 50
Large-scale testing (Phase 3)UnknownNCT05128643
What this trial is testing

Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Next Page